Molecules, Год журнала: 2024, Номер 29(22), С. 5481 - 5481

Опубликована: Ноя. 20, 2024

Acetylcholinesterase and butyrylcholinesterase are two related enzymes that represent pharmacologically suitable targets in neurodegenerative disorders, given their physiological roles the body. The treatment of disorders currently includes common reversible cholinesterase inhibitors. Resveratrol analogues, as molecules focus, have shown very strong inhibition potential cholinesterases. In this research, experimental DFT approaches for p

Язык: Английский